Efficacy of a Mobile Application and Semi-attendance Program in Bariatric Surgery
NCT ID: NCT06163235
Last Updated: 2025-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
72 participants
INTERVENTIONAL
2025-09-25
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
OBJECTIVES: The main objective is to evaluate the efficacy of a digital platform on mobile devices in obesity and bariatric surgery programs. Investigators will compare weight loss at 12 months after surgery in patients in the standard of care program and those in a semi-attendance program with digital support through a mobile application. As secondary objectives, it will be compared: (1) the number medical complications, the quality of life and satisfaction, physical activity, diet and attrition at 12 months after surgery. Investigators will also study the patient interaction with the platform and social networks.
TRIAL DESIGN: Randomized, non-inferiority clinical trial with a 12-month follow-up.
METHODS: 72 patients will be randomized (1: 1) to standard of care program and to semi-attendance program with digital support from the bariatric surgery program waiting list. Inclusion criteria: age between 18 and 60 years, body mass index between 35-50kg/m2, candidates for the sleeve gastrectomy technique, and possession of a mobile device. Participants will be evaluated before and 12 months after surgery. Variables: anthropometric measurements, medical complications during follow-up, quality of life, diet and physical activity questionnaires. Primary endpoint: weight loss 12 months after surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using the Standard Versus a More Intensified and Interactive Version of the "Get Ready" Smartphone Application.
NCT07297342
Does Text Message Support After Discharge Improve Outcomes Following Bariatric Surgery? A Randomised Trial.
NCT02341001
Efficacy of a Mobile Application to Help in Weight Loss Before Bariatric Surgery
NCT05598840
Reducing Sedentary Time in Obese Adults (Study 2)
NCT02160834
App-technology to Improve the Level of Physical Activity After Bariatric Surgery
NCT03480464
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Spain, the prevalence of obesity in adults has increased from 14% to 21.6% between 2003 and 2016. The category of obesity that has increased the most is severe obesity. Forecasts for the next ten years maintain that the increase will continue.
The two main problems of current bariatric surgery programs are the saturation of healthcare resources, and the losses to follow-up and long-term treatment adherence. Patients on the waiting list for bariatric surgery and who have completed the preoperative program can be found for a long period in a situation where there is no proactive specialized follow-up and without ability to consult with a multidisciplinary team.
On the other hand, loss to follow-up is another unresolved problem currently in bariatric units. Longer follow-up by specialized units has been associated with greater long-term weight loss. However, the loss to follow-up at 5 years can be as high as 40%, and even higher in the longer term. The already existing saturation of resources prior to the COVID-19 pandemic and the new limitations generated by it, have highlighted the need to reformulate bariatric surgery programs.
In this sense, the incorporation of digital platforms and applications for mobile devices can contribute to the digital transformation of the health care system to severe obesity.
Digitalisation offers numerous possibilities to provide educational material to patients, monitor their physical activity, or a more frequent and personalized follow-up.
The use of mobile applications has proven to be effective in losing weight in overweight patients without severe obesity, and in promoting the practice of physical activity. However, the majority of published studies use commercial mobile applications with very limited functionalities, so it has not been possible to evaluate all the multidisciplinary aspects involving a real bariatric patient follow-up.
To sum up, there is a lack of studies that analyze the full potential of digital platforms in patients with obesity and bariatric surgery. This project wants to design and test a mobile application in a randomized clinical trial, with multiple functionalities for mobile devices and that at the same time provides a safe and effective digital environment for patients included in bariatric surgery programs. Likewise, we want to evaluate the possible usefulness of the digital for the follow-up of these patients.
Methods and analysis Primary objective Assess the non-inferiority of a semi-presential program (40% reduction in face-to-face visits) with digital support compared with the conventional face-to-face follow-up program of the bariatric surgery program in the weight loss at 12 months after bariatric surgery.
Secondary objective
1. To compare postoperative weight loss at 3 and 6 months after bariatric surgery by semi-presential follow-up with digital support versus conventional face-to-face visit program.
2. To compare other secondary efficacy parameters at 12 months in the two follow-up arms:
2.1. Medical-surgical complications after surgery. 2.2. The quality of the diet. 23. The degree of physical activity. 2.4. Quality of life and degree of satisfaction with treatment. 2.5. Follow-up adherence. 2.6. Cost analysis.
Patients and public involvement Neither patients nor the public are involved in the conception, design or conduct of the study.
Study design Non-pharmacological, open-label, single center clinical trial to assess the impact of a semi-presential program with digital support through a mobile application in bariatric surgery programs.
Eligibility criteria for participants Patients suffering from severe obesity, candidates for treatment through bariatric surgery, on the waiting list for surgery at the Hospital del Mar in Barcelona. The inclusion of participants will be performed after obtaining the written informed consent approved by the ethical committee.
A) Inclusion criteria: patients between 18 and 65 years old who accept and understand the characteristics of the semi-presential program with digital support; BMI between 35-50kg/m2; sleeve gastrectomy, Roux-en-Y gastric bypass and SADI-S candidates.
B) Exclusion criteria: non-controlled psychiatric disorder; pregnancy desire in the next 12 months; do not have mobile devices; do not understand Spanish.
Blinding There will be no blinding with regard to the type of follow-up: patients as well as physicians and dietitians assessing follow-up data will be informed of the procedure performed.
Recruitment Participants will be recruited from the BS program at the Hospital del Mar, Barcelona. Patients who meet the NIH criteria for BS (BMI ≥40 kg/m2 or ≥35 kg/m2 with significant obesity-related comorbidities) and who express the desire to undergo BS will be referred to the BS unit from primary care units.
Inclusion visit(?) Preoperative management and postoperative follow-up
Prior to bariatric surgery, different examinations will be performed (abdominal ultrasound, functional respiratory tests and gastroscopy) and results evaluated by a multidisciplinary team including dietitian, surgeon and endocrinologist. Ten days prior to surgery, a very low-calorie diet will be prescribed to achieve additional weight loss.
The control group will make 30 face-to-face visits (16 preoperative and 14 postoperative), while the intervention group will make 11 face-to-face visits, 10 through online support and 9 telematic visits (7 face-to-face visits, 7 through online support and 2 telematic visits during the preoperative period and 4 face-to-face visits, 3 through online support and 7 telematic visits in the postoperative period). This is 40% fewer face-to-face visits in the second group. Both groups will have at their disposal the interaction with the medical team through social networks.
Randomization All patients who meet the inclusion criteria and do not present exclusion criteria will be randomized 1:1 in two parallel arms between the control group (face-to-face) and the intervention group (semi-presential).
Surgical procedures The present study contemplates laparoscopic Roux-en-Y gastric bypass, sleeve gastrectomy and SADI-S.
In order to avoid variability of response depending on the surgical technique and BMI, the study will be restricted to patients with obesity grade II-III (BMI between 35 and 50 kg/m2) who are candidates to bariatric surgery as a non-sequential technique.
The procedures are performed using a laparoscopic approach and involves a hospital stay of 1-2 days. All the procedures will be performed by the same surgical team.
Outcome definition
1. Main variable: weight loss at 12 months after bariatric surgery. It will be determined as the percentage of total weight loss \[%TWL= 100 x (Basal weight - Weight 12 months) / Basal weight\].
2. Secondary variables:
I. Medical-surgical complications: the variables corresponding to the biochemical and hematological determinations will be collected prior and 12 months after surgery. Surgical complications will be recorded using ordinal variables according to the Clavien-Dindo scale during the first 30 days after surgery. From the 30th day all complications will be recorded as a nominal variable. We will also record non-planned care activity that will include the number of emergency visits, readmissions and reinterventions.
II. Diet quality: it will be recorded using the "Short Diet Quality Screener" (sDQS) questionnaire validated in Spanish, before and 12 months after surgery.
III. Degree of physical activity: it will be evaluated using the reduced version of the physical activity questionnaire of Minnesota (Minnesota Leisure Time Physical Activity Questionnaire) before and 12 months after surgery, validated in Spanish. IV. Degree of satisfaction and quality of life: the first one will be recorded using a categorical scale. The second one Through the SF-36 quality of life questionnaire. V. Loss to follow-up: it will be collected as absence of visits for more than 6 months.
VI. To analyze the costs of both programs we will use the variables that encompass the set of healthcare activities carried out on all the patients attended, both in the emergency room, admissions, surgery and also in the outpatient setting, tests and examinations.
VII. To evaluate the behavior of patients in social networks and the same mobile application, we will use the variables of the length of the messages, the frequency of repetition of words, the periodicity of connection and participation in social networks, as well as the type of semantics used. In this sense, the team has a wide experience in the selection and collection of variables from social networks through the Application Programming Interface (API). The categorization of the digital phenotype according to the combination of variables can help to detect possible patterns of digital behavior that are capable of predicting the evolution of the disease.
Anthropometric parameters BMI will be calculated as weight in kilograms divided by the square of height in meters. Weight loss will be measured as percentage of total weight loss \[%TWL= 100 x (Basal weight - Weight 12 months) / Basal weight\].
Sample size Sample size has been calculated based on the primary objective to demonstrate the non-inferiority between treatments. Accepting an alpha risk of 0.05 and a beta risk of 0.2 in a unilateral contrast, 36 subjects are required in the first group and 36 in the second to detect a difference equal to or greater than 5 units in the %TWL. The common standard deviation is assumed to be 8. A loss-to-follow-up rate of 10%. As a contingency plan for possible missing values (missing data) in the covariates, we plan to carry out a multiple imputation analysis if necessary.
Data analysis
1. Primary outcome:
The analysis of weight loss at 12 months will be carried out using a model of multivariate analysis of variance including type of relationship with patients and gender as factors, and age and initial BMI as covariates. Likewise, a multiple linear regression model will be developed with these variables.
2. Secondary objectives will be evaluated respectively by:
1. Post-surgery complications will be analyzed using Fisher's exact tests.
2. The quality of the diet will be analyzed by a t-Student for independent samples.
3. Physical activity levels will be compared with the t-Student test for independent samples and for matched-samples.
4. The satisfaction and quality of life will be compared with a t-Student for independent samples.
5. Adherence to follow-up will be evaluated with a Poisson regression.
6. Economic analysis: Hospital del Mar has a cost information system based on costs (Full-costing) and distribution of costs by activities (ABC), which allows evaluating the set of assistance activities carried out on all the patients attended, both in emergencies, admissions, surgery and also in the outpatient setting, tests and explorations. For any patient selected in the study,
Ethics and dissemination
The study will be conducted in accordance with the basic principles of protection of rights and dignity of the human being, as stated in the Helsinki Declaration and with current regulations. All the information obtained will be treated confidentially in compliance with the personal data protection legislation (Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y garantía de los derechos digitales). Participants will sign their informed consent to participate in the study. Ethics approval has been granted by the Parc de Salut Mar Ethics Committee (2022-9964-I). The study and its conclusions regarding the primary and secondary objectives will be presented as manuscripts submitted for peer-reviewed journal publication.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Semi-attendance.
This group will follow a semi-attendance program after bariatric surgery.
Obemar platform
Online platform for education and follow-up
Control group.
This group will follow the conventional controls after bariatric surgery.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Obemar platform
Online platform for education and follow-up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bariatric surgery candidates
Exclusion Criteria
* Pregnancy desire in the next 12 months
* Do not have mobile devices (smartphone)
* Language barrier with Spanish.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Parc de Salut Mar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Casajoana, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital del Mar Research Institute
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI21/00551
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.